Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Large-scale testing (Phase 3)Ended earlyNCT04745832
What this trial is testing

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)

Who this might be right for
Follicular Lymphoma (FL)Non Hodgkin LymphomaMarginal Zone Lymphoma
MEI Pharma, Inc. 82
Not applicableStudy completedNCT03109223
What this trial is testing

Addition to Infant Formula of 2-fucosyllactose (2-FL)

Who this might be right for
Growth of Infants
PBM Nutritionals 221
Not applicableNot Yet RecruitingNCT06734624
What this trial is testing

The Microbiome in Blood Cancer and HLH

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Haemophagocytic Lymphohistiocytosis
University of Nottingham 750
Large-scale testing (Phase 3)UnknownNCT02097446
What this trial is testing

Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy

Who this might be right for
Genital Diseases, Female
Genewel Co., Ltd 60
Large-scale testing (Phase 3)Ended earlyNCT02793583
What this trial is testing

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaFollicular LymphomaMarginal Zone Lymphoma+2 more
TG Therapeutics, Inc. 710
Not applicableStudy completedNCT05529524
What this trial is testing

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 6
Not applicableStudy completedNCT00778297
What this trial is testing

Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 234
Testing effectiveness (Phase 2)Looking for participantsNCT07197307
What this trial is testing

Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Aggressive Diffuse Large B-cell LymphomaHigh-grade B-cell Lymphoma (HGBL)Follicular Lymphoma (FL) Grade 3B
Universität Münster 120
Testing effectiveness (Phase 2)Study completedNCT00394836
What this trial is testing

HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab

Who this might be right for
Lymphoma, Follicular
GlaxoSmithKline 116
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Not applicableStudy completedNCT04163406
What this trial is testing

The Effect of Human Milk Oligosaccharides and Galacto-oligosaccharides on Iron Absorption in Kenyan Infants

Who this might be right for
Anemia, Iron-deficiency
Swiss Federal Institute of Technology 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07731789
What this trial is testing

Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma

Who this might be right for
Classic Follicular LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+1 more
University of Washington 30
Large-scale testing (Phase 3)Study completedNCT01827605
What this trial is testing

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Who this might be right for
Relapsed Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 159
Testing effectiveness (Phase 2)Looking for participantsNCT06948786
What this trial is testing

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

Who this might be right for
Grade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+2 more
University of Washington 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03888105
What this trial is testing

Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Who this might be right for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Regeneron Pharmaceuticals 515
Testing effectiveness (Phase 2)Looking for participantsNCT07191249
What this trial is testing

Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .

Who this might be right for
Follicular Lymphoma
Tel-Aviv Sourasky Medical Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT07128641
What this trial is testing

Odronextamab in Low Tumor Volume Advanced FL

Who this might be right for
Follicular LymphomaLymphoma
Gottfried von Keudell, MD PhD 35
Early research (Phase 1)Looking for participantsNCT05131022
What this trial is testing

NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Diffuse Large B Cell Lymphoma (DLBCL)+6 more
Nurix Therapeutics, Inc. 572
Large-scale testing (Phase 3)Looking for participantsNCT06091254
What this trial is testing

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Regeneron Pharmaceuticals 822
Next Page